glp 1 drug examples GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Designing GLP-1 delivery: structural perspectives

278 : 4724547252 Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A and Barzilai A (2001) Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways

and enhanced physical endurance

Ahn SH, Edwards AK, Singh SS, Young SL, Lessey BA, Tayade C (2015) IL-17a contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors

Previous physiological studies have shown that both GIP (113116) and GLP-1 (117) act in concert with glucose to enhance insulin gene transcription, mRNA stability, insulin biosynthesis, and insulin secretion